LG Chem Life Sciences Announces First Participant Dosed in First-in-Human Study of SSAO Inhibitor LG00303174 in the United States
First-In-Human Study Targeting the Endothelial Cell-expressed Adhesion Molecule VAP1 CAMBRIDGE, Mass. & SEOUL, South Korea & NANJING, China–(BUSINESS WIRE)– LG Chem Life Sciences (“LG Chem”)...